Evidence map›Paper›PMID 31598669›Full record

Observational studyThe Journal of antimicrobial chemotherapy2020

Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD).

Patrick Rockenschaub, Arnoupe Jhass, Nick Freemantle, Anna Aryee, Meena Rafiq, Andrew Hayward, Laura Shallcross

Abstract readObservational Study
In one paragraph

Observational study in The Journal of antimicrobial chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Patrick RockenschaubInstitute of Health Informatics, University College London, 222 Euston Rd, London NW1 2DA, UK.
Arnoupe JhassPrimary Care & Population Health, University College London, Rowland Hill Street, London NW3 2PF, UK.
Nick FreemantleInstitute of Clinical Trials and Methodology, University College London, 90 High Holborn, London WC1V 6LJ, UK.
Anna AryeeInstitute of Health Informatics, University College London, 222 Euston Rd, London NW1 2DA, UK.
Meena RafiqInstitute of Health Informatics, University College London, 222 Euston Rd, London NW1 2DA, UK.
Andrew HaywardInstitute of Epidemiology & Healthcare, University College London, 1-19 Torrington Place, London WC1E 7HB, UK.
Laura ShallcrossInstitute of Health Informatics, University College London, 222 Euston Rd, London NW1 2DA, UK.

Funding

Department of Health CS-2016-16-007Wellcome Trust
6 · The paper itself

Abstract

backgroundIn primary care there is uncertainty about which patients with acute exacerbations of COPD (AECOPD) benefit from antibiotics.

objectivesTo identify which types of COPD patients get the most antibiotics in primary care to support targeted antibiotic stewardship.

methodsObservational study of COPD patients using a large English primary care database with 12 month follow-up. We estimated the incidence of and risk factors for antibiotic prescribing relative to the number of AECOPD during follow-up, considering COPD severity, smoking, obesity and comorbidity.

resultsFrom 157 practices, 19594 patients were diagnosed with COPD, representing 2.6% of patients and 11.5% of all prescribed antibiotics. Eight hundred and thirty-three (4.5%) patients with severe COPD and frequent AECOPD were prescribed six to nine prescriptions per year and accounted for 13.0% of antibiotics. Individuals with mild to moderate COPD and zero or one AECOPD received one to three prescriptions per year but accounted for 42.5% of all prescriptions. In addition to COPD severity, asthma, chronic heart disease, diabetes, heart failure and influenza vaccination were independently associated with increased antibiotic use.

conclusionsPatients with severe COPD have the highest rates of antibiotic prescribing but most antibiotics are prescribed for patients with mild to moderate COPD. Antibiotic stewardship should focus on the dual goals of safely reducing the volume of prescribing in patients with mild to moderate COPD, and optimizing prescribing in patients with severe disease who are at significant risk of drug resistance.

Indexed as

Practice Patterns, Physicians'AdultAgedAged, 80 and overAnti-Bacterial AgentsAntimicrobial StewardshipDrug PrescriptionsElectronic Health RecordsFemaleHumansMaleMiddle AgedPrimary Health CarePulmonary Disease, Chronic ObstructiveRetrospective StudiesRisk FactorsAnti-Bacterial Agents

Identifiers

PMID31598669
PMCPMC6910166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.